Skip to content
Screener

Tandem Diabetes Care TNDM Pump — Sales

Other product segments

Supplies and other
$139.91M+8.6%

Similar metrics at other companies

DXP Enterprises logo
DXPEOrganic Sales — Sales
$526.61M+11.1%
DXP Enterprises logo
DXPEAcquisition Sales — Sales
$49.85M+103%
Aebi Schmidt Holding logo
AEBIAfter Sales — Sales
$73.88M+59.6%
Vontier logo
VNTSales of products — Sales
$691.9M+0.9%
Vontier logo
VNTSales of services — Sales
$64.8M-26.1%
Village Super Market logo
VLGEANet Merchandise Sales — Sales
$569.11M+1.4%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.56B+132%
Enterprise value$2.23B+112%
P/S1.5×+0.8×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Pump$114,652$111,871$225,078$213,962
Supplies and other139,908128,807276,703261,138
Total Sales$254,560$240,678$501,781$475,100

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's pump — sales?
Tandem Diabetes Care (TNDM) reported pump — sales of $114.65M in Q2 2026.
How has Tandem Diabetes Care's pump — sales changed year-over-year?
Tandem Diabetes Care's pump — sales increased by 2.5% year-over-year, from $111.87M to $114.65M.
What is the long-term trend for Tandem Diabetes Care's pump — sales?
Over 3 years (2022 to 2025), Tandem Diabetes Care's pump — sales has grown at a 2.4% compound annual growth rate (CAGR), from $431.91M to $464.15M.
What does pump — sales mean?
This metric represents the total revenue generated from the sale of durable insulin delivery devices and associated hardware components. It serves as a primary indicator of market adoption for the company's core medical device technology and reflects the success of product lifecycle management. Tracking this revenue stream helps investors assess the company's competitive position within the insulin pump market and the impact of new product launches on top-line growth.

Ask your AI about Tandem Diabetes Care's pump — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude